TRIAP1 and prostate cancer: Interestingly, immunohistological analysis of TRIAP1 in advanced human prostate cancer reveals increased TRIAP1 immunoreactivity in the malignant epithelial cells of the more radioresistant higher Gleason grade adenocarcinomas.